Buck E. Rogers

6.5k citations

126 papers · 5.0k indexed · h-index 40

Oncology top 1%
- Peptidase Inhibition and Analysis 18
Radiology, Nuclear Medicine and Imaging top 0.5%
- Radiopharmaceutical Chemistry and Applications 58
- Monoclonal and Polyclonal Antibodies Research 20
- Medical Imaging Techniques and Applications 14
Genetics top 1%
- Virus-based gene therapy research 19
Biotechnology top 2%
- Cancer Research and Treatments 11
Molecular Biology top 5%
Epidemiology
- Neuroendocrine Tumor Research Advances 17
Pulmonary and Respiratory Medicine
- Prostate Cancer Treatment and Research 9

Co-authors: David T. Curiel Kurt R. Zinn Donald J. Buchsbaum Carolyn J. Anderson Jesse J. Parry Joanne T. Douglas Rebecca Andrews Michael J. Welch
Cited by: Oncology Radiology, Nuclear Medicine and Imaging Genetics
Journals: Journal of Nuclear Medicine (9 papers)Nuclear Medicine and Biology (9 papers)Bioconjugate Chemistry (8 papers)
Partner nations: United States Canada France

In The Last Decade

Buck E. Rogers

125 papers receiving 4.9k citations

Peers

Countries citing papers authored by Buck E. Rogers

Since Specialization

Citations

This map shows the geographic impact of Buck E. Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Buck E. Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Buck E. Rogers more than expected).

Fields of papers citing papers by Buck E. Rogers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Buck E. Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Buck E. Rogers. The network helps show where Buck E. Rogers may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Buck E. Rogers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Buck E. Rogers Line = papers co-authored together Buck E. Rogers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of a [89Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library Clinical Cancer Research ·Abhay K. Singh,K Nakashima,Martín Leonardo,聂晓霞,А.В. Братусь,Rogério M. L. Silva,Thorsten Junkermann,Young Ah Goo,A. Rosner,Michael L. Nickels,Yongjian Liu,Buck E. Rogers,Vaishali Kapoor,Dennis E. Hallahan	2024	2
2	Functional network disorganization and cognitive decline following fractionated whole-brain radiation in mice GeroScience ·Benjamin A. Seitzman,Francisco J. Reynoso,Timothy J. Mitchell,Annie R. Bice,Ming Zhou,Xiaodan Wang,Cedric Mpoy,Daniel Lynn Helms,Buck E. Rogers,Carla M. Yuede,Joshua B. Rubin,Stephanie M. Perkins,Adam Q. Bauer	2023	5
3	Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer Journal of Nuclear Medicine ·Nadia Benabdallah,Jorge Mezquita,Diane S. Abou,Hanwen Zhang,David Ulmert,Robert F. Hobbs,Hiram A. Gay,Brian W. Simons,Muhammad A. Saeed,Buck E. Rogers,Abhinav K. Jha,Yuan‐Chuan Tai,Christopher Malone,Joseph E. Ippolito,Jeff M. Michalski,Jack W. Jennings,Brian C. Baumann,Russell K. Pachynski,Daniel L.J. Thorek	2023	6
4	Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade Cancer Discovery ·Varintra E. Lander,Jad I. Belle,Natalie L. Kingston,John M. Herndon,Graham D. Hogg,Xiuting Liu,Liang‐I Kang,Brett L. Knolhoff,勝徳竹内,John Baer,Chong Zuo,Nicholas Borcherding,Hesham Metwalli Mousli,Cedric Mpoy,Jalen Scott,Michael C. Zahner,Buck E. Rogers,Julie K. Schwarz,Hyun Kim,David G. DeNardo	2022	66
5	2-(4-Hydroxyphenyl)benzothiazole dicarboxylate ester TACN chelators for ⁶⁴ Cu PET imaging in Alzheimer's disease Dalton Transactions ·Yujue Wang,Truc T. Huynh,Nilantha Bandara,Hong‐Jun Cho,Buck E. Rogers,Liviu M. Mirica	2021	10
6	Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads Proceedings of the National Academy of Sciences ·Danielle M. Lussier,Elise Alspach,Jeffrey P. Ward,Alexander P. Miceli,Daniele Runci,J. Michael White,Cedric Mpoy,Cora D. Arthur,Madhusmita Lakra,Tyler Jacks,Maxim N. Artyomov,Buck E. Rogers,Robert D. Schreiber	2021	93
7	Design of a multivalent bifunctional chelator for diagnostic ⁶⁴ Cu PET imaging in Alzheimer’s disease Proceedings of the National Academy of Sciences ·Irma Bastaman,Truc T. Huynh,Buck E. Rogers,Liviu M. Mirica	2020	28
8	Metal-chelating benzothiazole multifunctional compounds for the modulation and ⁶⁴ Cu PET imaging of Aβ aggregation Chemical Science ·Yiran Huang,Irma Bastaman,Nilantha Bandara,Liang Sun,Diana Tran,Buck E. Rogers,Liviu M. Mirica	2020	46
9	Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart JCI Insight ·Luigi Adamo,Cibele Rocha‐Resende,Chieh‐Yu Lin,Sarah Evans,Jesse W. Williams,Hao Dun,Wenjun Li,Cedric Mpoy,Prabhakar S. Andhey,Buck E. Rogers,Kory J. Lavine,Daniel Kreisel,Maxim N. Artyomov,Gwendalyn J. Randolph,Douglas L. Mann	2020	72
10	Structure-activity relationship studies and bioactivity evaluation of 1,2,3-triazole containing analogues as a selective sphingosine kinase-2 inhibitors European Journal of Medicinal Chemistry ·Vijai Kumar Reddy Tangadanchu,Hao Jiang,Yanbo Yu,Thomas J. A. Graham,Hui Liu,Buck E. Rogers,Robert J. Gropler,Joel S. Perlmutter,Zhude Tu	2020	10
11	⁶⁴Cu-Labeled Somatostatin Analogues Conjugated with Cross-Bridged Phosphonate-Based Chelators via Strain-Promoted Click Chemistry for PET Imaging: In silico through in Vivo Studies Journal of Medicinal Chemistry ·Zhengxin Cai,Qin Ouyang,Dexing Zeng,Kim Nguyễn,Franklin Andrés Pineda Álvarez,Lirong Wang,Alexander G. White,Buck E. Rogers,Xiang‐Qun Xie,Carolyn J. Anderson	2014	30
12	Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor Journal of Nuclear Medicine ·Bernadette Marquez‐Nostra,Oluwatayo Ikotun,Jesse J. Parry,Buck E. Rogers,Claude F. Meares,Suzanne E. Lapi	2014	7
13	AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake PLoS ONE ·Ramachandran Rashmi,Carl J. DeSelm,Cynthia Helms,A. Bowcock,Buck E. Rogers,Janet S. Rader,Perry W. Grigsby,Julie K. Schwarz	2014	74
14	Positron-emission tomography (PET) imaging agents for diagnosis of human prostate cancer: agonist vs. antagonist ligands. PubMed ·Prasant Kumar Nanda,Dong-Su Sun,Tammy L. Rold,Gary L. Sieckman,好弘加藤,Timothy J. Hoffman,Buck E. Rogers,Charles J. Smith	2012	17
15	Mutant p53 Disrupts the Stress MAPK Activation Circuit Induced by ASK1-Dependent Stabilization of Daxx Cancer Research ·Tetsuya Kitamura,Yayoi Fukuyo,Masahiro Inoue,Fr. Babinger,Masanobu Shindoh,Buck E. Rogers,Anny Usheva,Nobuo Horikoshi	2009	18
16	Intraperitoneal Radioimmunotherapy with a Humanized Anti-TAG-72 (CC49) Antibody with a Deleted CH2 Region Cancer Biotherapy and Radiopharmaceuticals ·Buck E. Rogers,Peter L. Roberson,Sui Shen,M.B. Khazaeli,Mark Carpenter,Shigeru Yokoyama,Martin W. Brechbiel,Albert F. LoBuglio,Donald J. Buchsbaum	2005	19
17	Three-Dimensional Dose Model for the Comparison of ¹⁷⁷ Lu-HuCC49ΔCH2 and ¹⁷⁷ Lu-HuCC49 Radioimunotherapy in Mice Bearing Intraperitoneal Xenografts Cancer Biotherapy and Radiopharmaceuticals ·Peter L. Roberson,Shigeru Yokoyama,Buck E. Rogers,Donald J. Buchsbaum	2003	3
18	Evaluation of the in vitro stability of gadolinium (III) polyoxometalates Nuclear Medicine and Biology ·K Kelley,Gregory R. Choppin,Buck E. Rogers,Michael J. Welch	1997	10
19	Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin‐releasing peptide receptor by an adenoviral vector Cancer ·Buck E. Rogers,David T. Curiel,Matthew S. Mayo,Vishal G. Saravade,N. R. Sardar,Donald J. Buchsbaum	1997	11
20	Targeted gene delivery by tropism-modified adenoviral vectors Nature Biotechnology ·Joanne T. Douglas,Buck E. Rogers,Masaki DAIKU,Jose L. Juarez-Perez,Meizhen Feng,David T. Curiel	1996	348

About Buck E. Rogers

Buck E. Rogers is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Biotechnology, Genetics and Immunology and Allergy, having authored 126 papers that have together received 5.0k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (58 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Virus-based gene therapy research (19 papers), Peptidase Inhibition and Analysis (18 papers), Neuroendocrine Tumor Research Advances (17 papers), Medical Imaging Techniques and Applications (14 papers), Cancer Research and Treatments (11 papers) and Prostate Cancer Treatment and Research (9 papers). The work is most often cited by research in Oncology (2.0k citations), Radiology, Nuclear Medicine and Imaging (1.7k citations), Genetics (1.2k citations), Biotechnology (295 citations) and Molecular Biology (1.8k citations). Buck E. Rogers has collaborated with scholars based in United States, Canada and France. Frequent co-authors include David T. Curiel, Kurt R. Zinn, Donald J. Buchsbaum, Carolyn J. Anderson, Jesse J. Parry, Joanne T. Douglas, Rebecca Andrews, Michael J. Welch, Cedric Mpoy and Tandra R. Chaudhuri. Their work appears in journals such as Journal of Nuclear Medicine, Nuclear Medicine and Biology, Bioconjugate Chemistry, Inorganic Chemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact